Company News in the Life Science Industry

»

Reset 

New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes

THOUSAND OAKS, Calif., Sept. 15, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that a new analysis of the cardiovascular outcomes study (FOURIER) demonstrated that lowering low-density lipoprotein cholesterol (LDL-C) levels with Repatha(®) (evolocumab) significantly and consistently... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Amgen, Inc.

Global $6.6 Bn In-Vitro Diagnostics (IVD) Packaging Market, 2022

DUBLIN, Sept. 15, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Nanobiotechnology Applications, Markets and Companies 2017-2026 - Profiles of 250+ Companies & 183 Collaborations

DUBLIN, Sept. 15, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Global Consumer and Recreational Oxygen Equipment Markets, 2023

DUBLIN, Sept. 15, 2017 /PRNewswire/ -- The "Consumer and Recreational Oxygen Equipment: Market Shares, Strategies, and Forecasts, Worldwide 2017 - 2023" report from Wintergreen Research,... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Global Cardiovascular Drug Delivery Markets 2016-2026 - Technologies, Markets and Companies Report 2017

DUBLIN, Sept. 15, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Global $39 Bn Radiation Detection Materials and Equipment Markets, 2026

DUBLIN, Sept. 15, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Global $20 Billion Medical Robotics Market to 2022

DUBLIN, Sept. 15, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

BioAxone BioSciences Awarded NINDS SBIR Funding for the Development of Self-Delivering RNAi (sd-rxRNA®) for the Treatment of Spinal Cord Injury

CAMBRIDGE, Mass. and MARLBOROUGH, Mass., Sept. 15, 2017 /PRNewswire/ -- BioAxone BioSciences, Inc. announced today that, as part of a collaborative effort with RXi Pharmaceuticals Corporation (NASDAQ: RXII), it is the recipient of a grant award from the National Institute of Neurological Disorders... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  RXi Pharmaceuticals Corporation

Biotech Stocks on Investors' Radar -- Clovis Oncology, Dermira, Editas Medicine, and Endocyte

NEW YORK, September 15, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Clovis Oncology | Endocyte, Inc. | Dermira Inc. | Editas Medicine, Inc.

Santhera Receives Negative Opinion from the CHMP for its Marketing Authorization Application for Raxone® in DMD and Intends to Appeal this Opinion

Read more ››
By: Nasdaq / GlobenewsWire - 15 Sep 2017
Related companies:  Santhera Pharmaceuticals (Schweiz) AG

Fagron NV: Disclosure of received notification

Read more ››
By: Nasdaq / GlobenewsWire - 15 Sep 2017
Related companies:  Fagron Group BV

Herantis Pharma receives Life Sciences Nordic Stars Award

Read more ››
By: Nasdaq / GlobenewsWire - 15 Sep 2017

FIT Biotech Oy: FIT BIOTECH OY HALF-YEARLY FINANCIAL REPORT JANUARY 1 - JUNE 30, 2017

Read more ››
By: Nasdaq / GlobenewsWire - 15 Sep 2017

Skåne University Hospital Becomes First Clinic in Sweden To Use Acarix CADScor®System For Early Rule-Out Of Coronary Artery Disease

Read more ››
By: Nasdaq / GlobenewsWire - 15 Sep 2017
Related companies:  Acarix A/S

CSL Behring Announces FDA Approval of Privigen® [Immune Globulin Intravenous (Human), 10% Liquid] for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Adults

KING OF PRUSSIA, Pa., Sept. 14, 2017 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has approved Privigen(®) [Immune Globulin Intravenous (Human),... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  CSL Behring

New indication for BRIVIACT® (brivaracetam): UCB's newest antiepileptic drug approved by FDA as monotherapy treatment of partial-onset seizures in adults

ATLANTA and BRUSSELS, Sept. 15, 2017 /PRNewswire/ -- UCB announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for BRIVIACT(® )(brivaracetam) CV as monotherapy for partial-onset (focal) seizures (POS) in patients 16 years and... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  UCB Biopharma SPRL

DaVita Kidney Care Issues Statement about Florida Boil Water Advisory

DENVER, Sept. 14, 2017 /PRNewswire/ -- The following media statement is attributed to Dr. Martin Schreiber, vice president, clinical affairs for DaVita Kidney Care.

Read more ››
By: PR Newswire Association LLC. - 15 Sep 2017

COPAN Installs Landmark, 60th WASPLab(TM) at Prestigious University Health Network/Sinai Health System Department of Microbiology in Canada

MURRIETA, Calif., Sept. 14, 2017 /PRNewswire/ -- It isn't every day that a company hits four milestones with the placement of one system. But that is exactly what happened last month at the University Health Network/Sinai Health System's Department of Microbiology in Toronto, Ontario when COPAN... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2017

Emergency Nurses Association Prepares Nurses to Respond to Natural Disasters and Mass Casualty Incidents

DES PLAINES, Ill., Sept. 14, 2017 /PRNewswire/ -- In the midst of a historical hurricane season, emergency responders in hard-hit areas are faced with an influx of seriously injured patients. Operations can be made even more difficult by conditions like flooded roads, debris, high winds and loss... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2017

Array BioPharma Announces Pricing of Public Offering of Common Stock

BOULDER, Colo., Sept. 14, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) announced today the pricing of an underwritten public offering of 20,930,232 shares of its common stock at a public offering price of $10.75 per share. The gross proceeds from the sale of the shares, before underwriting... Read more ››

By: PR Newswire Association LLC. - 15 Sep 2017
Related companies:  Array BioPharma Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18 19  20  21  22  23  24  25 »

Explore our database of over 40,000 companies